NTLA
Intellia Therapeutics Inc.
$24.23
-$0.29(-1.18%)
69
Overall
60
Value
100
Tech
47
Quality
Market Cap
$2.19B
Volume
5.85M
52W Range
$5.90 - $26.99
Target Price
$33.46
Key Metrics Overview
| Market Cap | $2.19B | P/E Ratio | N/A |
| 52W High | $26.99 | 52W Low | $5.90 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 0.0% | 52W Position | 86.9% |
| Overall Score | 69 | Value Score | 60 |
| Quality Score | 47 | Technical Score | 100 |
Growth Analysis
| EPS Current Est | $-4.09 | EPS Next Est | $-3.97 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $24.23 | -1.2% | 5.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW